SCHEMBL22019928

SCHEMBL22019928

CC(C)n1cc(S(=N)(N)=O)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.40
NLRP3 Q96P20 1/20 0.40
NAMPT P43490 10/20 0.36
CYP2C9 P11712 5/20 0.35
CYP2C19 P33261 2/20 0.35
PRMT5 O14744 1/20 0.34
WDR77 Q9BQA1 1/20 0.34
CYP3A4 P08684 2/20 0.34
SYK P43405 1/20 0.32
MKNK1 Q9BUB5 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32
AURKA O14965 1/20 0.32
LIMK1 P53667 1/20 0.32
AURKB Q96GD4 1/20 0.32
PIK3CD O00329 1/20 0.32
PIP5K1C O60331 1/20 0.32
PIK3CA P42336 1/20 0.32
PI4KA P42356 1/20 0.32
PIK3CG P48736 1/20 0.32
PI4KB Q9UBF8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18029805 0.85 ACHE (0.42) ACHENLRP3NAMPTCYP2C9CYP2C19
SCHEMBL22019927 0.82 ACHE (0.40) ACHENLRP3NAMPTCYP2C9CYP2C19
SCHEMBL18007714 0.78 NLRP3 (0.44) ACHENLRP3NAMPTCYP2C9CYP2C19
Hydrochloric Acid SCHEMBL28184544 0.76 ACHE (0.45) ACHENLRP3NAMPTCYP2C9CYP2C19
SCHEMBL15690483 0.73 CYP2C9 (0.50) NAMPTCYP2C9CYP2C19CYP3A4
SCHEMBL21963145 0.72 ACHE (0.35) ACHENLRP3NAMPTCYP2C9CYP2C19
SCHEMBL173773 0.70 NAMPT (0.52) NAMPTCYP2C9CYP2C19PRMT5WDR77
SCHEMBL24979080 0.70 NLRP3 (0.44) ACHENLRP3NAMPTCYP2C9CYP2C19
Hydrochloric Acid SCHEMBL16107549 0.69 NAMPT (0.51) NAMPTCYP2C9CYP2C19PRMT5WDR77
Hydrochloric Acid SCHEMBL29505562 0.69 ACHE (0.41) ACHENAMPTAURKALIMK1AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed